Kaiser Health News (1/16, Andrews) reports on whether a 3-D mammogram is more effective than “the standard test.” The article says that research has “generally shown that the 3-D test is slightly better at detecting cancers than the 2-D test,” but there is doubt as to whether the 3-D tests are “any better at identifying the advanced cancers that will become lethal.” Dr. Etta Pisano, chief science officer at the American College of Radiology’s Center for Research and Innovation, explained, “Cancers don’t always progress and kill people.” She added, “Costs are high for new technologies. ... Maybe they are better, but we need to have evidence before we recommend it for the entire population.”
The AP (1/16) reports the Wisconsin Assembly has passed a bill Tuesday to require mammogram providers to notify female patients if they have dense breast tissue, which “supporters say...will help them make better health choices since it’s more difficult to detect cancerous tumors in women with dense breast tissue.” Through the legislation, providers must “give women a notice explaining that they have what is known as ‘dark tissue’ and they can talk with their doctor about whether they need additional cancer screening.” The bill will go to the state Senate.
Aunt Minnie (1/12) reports a new study published in Clinical Imaging recommends that “incidental breast lesions detected in women receiving chest CT exams” should be followed up on, and suggests “that a new reporting scale similar to BI-RADS be used to classify the findings.” The study concluded that “radiologists examining CT scans spotted 82% of the nodules identified on mammograms.” Lead author Dr. Laurie Margolies from Mount Sinai Health System explained, “My great fear is that there will be a group of women who won’t have yearly mammograms anymore...and there is a danger that some of these women will develop cancers,” adding, “if those women happen also to be getting chest CT exams...we do have the opportunity to look at the breast [and] see some things on the order of incidental findings.”
Diagnostic Imaging (1/11) reports that research suggests “contrast-enhanced digital mammography (CEDM) could be valuable as a supplemental imaging exam for women at increased risk for breast cancer who do not meet the criteria for MRI or for whom access to MRI is limited.” The findings were published in the European Journal of Radiology.
The Radiology Business Journal (1/10, Walter) reports that research suggests that “if preoperative MR imaging reveals the presence of peritumoral edema in a patient with invasive breast cancer, it could be a sign of disease recurrence later on.” The findings were published in Radiology.